By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Chemically known as tirzepatide, Mounjaro is currently sold in the UK and Europe under the same brand name for both diabetes ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

A new study in The Journal of Immunology reveals how a high-fat diet may impair the immune system's ability to respond to infection by impacting the function of neutrophils, one of the first immune ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Researchers have discovered that a drug originally developed for conditions like Alzheimer’s disease, schizophrenia, and ...

Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...

Oklahoma City ranks 12th among the nation's most overweight cities, with one of the highest adult obesity rates, despite past ...

Childhood obesity is a pandemic that continues to threaten the health of children in the UK, despite several calls for action over the years.